A Chrysin Derivative Suppresses Skin Cancer Growth by Inhibiting Cyclin-dependent Kinases
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Chrysin Derivative Suppresses Skin Cancer Growth by Inhibiting Cyclin-dependent Kinases
Authors
Keywords
-
Journal
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 288, Issue 36, Pages 25924-25937
Publisher
American Society for Biochemistry & Molecular Biology (ASBMB)
Online
2013-07-26
DOI
10.1074/jbc.m113.464669
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- New Directions in Targeting Protein Kinases: Focusing Upon True Allosteric and Bivalent Inhibitors
- (2012) Vandana Lamba et al. CURRENT PHARMACEUTICAL DESIGN
- Discovery of a Potential Allosteric Ligand Binding Site in CDK2
- (2011) Stephane Betzi et al. ACS Chemical Biology
- (3-Chloroacetyl)-indole, a Novel Allosteric AKT Inhibitor, Suppresses Colon Cancer Growth In Vitro and In Vivo
- (2011) D. J. Kim et al. Cancer Prevention Research
- Molecular Mechanisms of Cardiovascular Toxicity of Targeted Cancer Therapeutics
- (2010) Hui Cheng et al. CIRCULATION RESEARCH
- 7,3′,4′-Trihydroxyisoflavone Inhibits Epidermal Growth Factor-induced Proliferation and Transformation of JB6 P+ Mouse Epidermal Cells by Suppressing Cyclin-dependent Kinases and Phosphatidylinositol 3-Kinase
- (2010) Dong Eun Lee et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Synthesis of C(7) modified chrysin derivatives designing to inhibit β-ketoacyl-acyl carrier protein synthase III (FabH) as antibiotics
- (2009) Huan-Qiu Li et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Design, synthesis and biological evaluation of chrysin long-chain derivatives as potential anticancer agents
- (2009) Peng-Cheng Lv et al. BIOORGANIC & MEDICINAL CHEMISTRY
- A Regulatory Mechanism for RSK2 NH2-Terminal Kinase Activity
- (2009) Y.-Y. Cho et al. CANCER RESEARCH
- The Development of a Selective Cyclin-Dependent Kinase Inhibitor That Shows Antitumor Activity
- (2009) S. Ali et al. CANCER RESEARCH
- A Novel Class of Cyclin-dependent Kinase Inhibitors Identified by Molecular Docking Act through a Unique Mechanism
- (2009) Patrick Corsino et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cyclin-Dependent Kinase 3-Mediated Activating Transcription Factor 1 Phosphorylation Enhances Cell Transformation
- (2008) D. Zheng et al. CANCER RESEARCH
- Raf and MEK Protein Kinases Are Direct Molecular Targets for the Chemopreventive Effect of Quercetin, a Major Flavonol in Red Wine
- (2008) K. W. Lee et al. CANCER RESEARCH
- The resveratrol analogue 3,5,3′,4′,5′-pentahydroxy-trans-stilbene inhibits cell transformationviaMEK
- (2008) Ki Won Lee et al. INTERNATIONAL JOURNAL OF CANCER
- Cocoa Procyanidins Suppress Transformation by Inhibiting Mitogen-activated Protein Kinase Kinase
- (2008) Nam Joo Kang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cyclin E and SV40 Small t Antigen Cooperate to Bypass Quiescence and Contribute to Transformation by Activating CDK2 in Human Fibroblasts
- (2008) Elena Sotillo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Fyn is a novel target of (−)-epigallocatechin gallate in the inhibition of JB6 Cl41 cell transformation
- (2007) Zhiwei He et al. MOLECULAR CARCINOGENESIS
- CDK inhibitors in cancer therapy: what is next?
- (2007) Marcos Malumbres et al. TRENDS IN PHARMACOLOGICAL SCIENCES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search